Released Aug 3, 2017, after the close
10-Q filed Aug 3, 2017, 34 days after period end · 0001558370-17-005864
Q2 2017 · 10-Q
Revenue$65.08M$65.08M +19.7% vs Q2 2016+24.7% vs Q1 2017
Net Income-$44.22M-$44.22M N/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$0.30-$0.30 N/M vs Q2 2016N/M vs Q1 2017
Operating Income-$41,011,000N/M
Operating Cash Flowderived-$32,451,000N/M
Free Cash Flowderived-$33,160,000N/M
Margins · derived
Operating margin-63.0%−34.8 pt vs Q2 2016
Net margin-68.0%−28.0 pt vs Q2 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $65.08M | $54.35M | $27.74M | $6.84M |
| Net Income | -$44.22M | -$21.70M | — | — |
| EPS Diluted | -$0.30 | -$0.15 | -$0.34 | -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR